Crescita Therapeutics Company Top Insiders
CRRTF Stock | USD 0.39 0.00 0.00% |
Crescita Therapeutics employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Crescita Therapeutics' management performance can provide insight into the company performance.
Dominic KingSmith Insider VP Devel |
Francois Lafortune Insider Ex GM |
Crescita |
Crescita Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of 0.0227 % which means that it generated a profit of $0.0227 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0318 %, meaning that it generated $0.0318 on every $100 dollars invested by stockholders. Crescita Therapeutics' management efficiency ratios could be used to measure how well Crescita Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Crescita Therapeutics Workforce Comparison
Crescita Therapeutics is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 9,640. Crescita Therapeutics adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. Crescita Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Crescita Therapeutics Price Series Summation is a cross summation of Crescita Therapeutics price series and its benchmark/peer.
Crescita Therapeutics Notable Stakeholders
A Crescita Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Crescita Therapeutics often face trade-offs trying to please all of them. Crescita Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Crescita Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dominic KingSmith | VP Devel | Profile | |
Francois Lafortune | Ex GM | Profile |
About Crescita Therapeutics Management Performance
The success or failure of an entity such as Crescita Therapeutics often depends on how effective the management is. Crescita Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Crescita management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Crescita management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.
Crescita Therapeutics Workforce Analysis
Traditionally, organizations such as Crescita Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Crescita Therapeutics within its industry.Crescita Therapeutics Manpower Efficiency
Return on Crescita Therapeutics Manpower
Revenue Per Employee | 8.4M | |
Revenue Per Executive | 8.4M | |
Net Loss Per Employee | 552.5K | |
Net Loss Per Executive | 552.5K |
Complementary Tools for Crescita Pink Sheet analysis
When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stocks Directory Find actively traded stocks across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |